ADVFN Logo

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

BIIB Biogen Inc

215,6271
-0,7129 (-0,33%)
28 Mar 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Biogen Inc BIIB NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,7129 -0,33% 215,6271 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
217,36 214,00 217,57 215,63 216,34
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/03/202409:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
04/03/202418:15GLOBEBiogen Highlights New Data at the International Conference..
23/02/202409:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
12/02/202418:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
19/12/202309:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202311:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202308:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
08/11/202310:19IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
06/11/202309:30GLOBEBiogen Appoints Monish Patolawala to its Board of Directors
26/10/202308:08IHMARKETNEWSThursday’s Wall Street Highlights: Ford, Morgan Stanley,..
25/10/202318:26GLOBEEisai Presents New LEQEMBI® (lecanemab-irmb) Investigational..
25/10/202318:25PRNUSEISAI PRESENTS NEW LEQEMBI® (LECANEMAB-IRMB) INVESTIGATIONAL..
25/10/202311:51GLOBENew Data from Biogen’s Investigational Antisense..
24/10/202310:30PRNUSLEQEMBI® (lecanemab-irmb) NAMED ONE OF TIME's BEST..
19/10/202308:30GLOBEBiogen to Present New Data at the Clinical Trials on..
19/10/202307:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
04/10/202309:15IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
29/09/202317:49DJNBiogen's Tofidence Intravenous Formulation Gets FDA Approval
29/09/202317:06GLOBEFDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a..
26/09/202309:59GLOBEBiogen Completes Acquisition of Reata Pharmaceuticals
25/09/202302:02GLOBELEQEMBI® Intravenous Infusion (Lecanemab) Approved for the..
06/09/202308:30GLOBEBiogen Appoints Jane Grogan as Head of Research
05/09/202309:24IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
25/08/202309:50IHMARKETNEWSFriday’s Wall Street Highlights: Hawaiian Electric, Disney,..
08/08/202308:51IHMARKETNEWSTuesday’s Wall Street Highlights: Novo Nordisk, RingCentral,..
07/08/202309:18DJNSage Therapeutics Shares Slide Premarket After Zurzuvae MDD..
07/08/202308:26IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
04/08/202323:42BWFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
04/08/202323:41GLOBEFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
31/07/202308:20IHMARKETNEWSMonday’s Wall Street Highlights: Palantir Technologies,..
28/07/202308:05GLOBEBiogen to Acquire Reata Pharmaceuticals
26/07/202308:27IHMARKETNEWSWednesday’s Wall Street Highlights: Microsoft, Coca-Cola,..
19/07/202320:30GLOBEEisai Presents Latest Analysis of Lecanemab’s Effect on..
10/07/202308:50IHMARKETNEWSMonday’s Wall Street Highlights: Icahn Enterprises,..
07/07/202308:51IHMARKETNEWSFriday’s Wall Street Highlights: Alibaba, Biogen, Uber,..
07/07/202301:39DJNTrending: Eisai, Biogen's Alzheimer's Treatment Gets Full..
06/07/202321:00GLOBEFDA Grants Traditional Approval for LEQEMBI®..
30/06/202317:06GLOBENew Data at Cure SMA Highlight Potential Benefit of..
12/06/202318:14GLOBEBiogen Announces Changes to Its Board of Directors
09/06/202319:45GLOBEFDA Advisory Committee Votes Unanimously to Confirm the..
18/05/202309:00PRNCASANTÉ CANADA ACCEPTE LA PRÉSENTATION DE NOUVEAU MÉDICAMENT..
15/05/202320:30GLOBEHealth Canada Accepts New Drug Submission for Lecanemab as..
25/04/202316:04GLOBEFDA Grants Accelerated Approval for QALSODY™ (tofersen) for..
12/04/202309:00GLOBEBiogen Exercises Option with Denali to Develop and..
04/04/202308:30GLOBEBiogen Appoints Adam Keeney as Head of Corporate Development
30/03/202320:31PRNUSADDITIONAL DETAILED ANALYSES FROM PHASE 2 STUDY 201 OF..
30/03/202320:30GLOBEAdditional Detailed Analyses From Phase 2 Study 201 of..

Seu Histórico Recente

Delayed Upgrade Clock